CERo Therapeutics Holdings, Inc.

CEROOTCHealthcare● Active

$0.01

+$0.00(+11.01%)

Market Cap$14464

P/E Ratio—

52W High$26.99

52W Low$0.01

Avg Volume605K

Open$0.01

Beta0.12

Insider Trades Ownership Employees

CERo Therapeutics Holdings, Inc.（CERO）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · CERO · 截至 2026年6月9日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

0.00

Buy/Sell (by trades)

整体情绪

偏空

↑ Buy 0%仅显示有效交易 · 排除RSU归属100% Sell ↓

CERo Therapeutics Holdings, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月9日

CERO 季度内部人买卖趋势

CERO 内幕交易卖出 · CERO 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

25.6M12.8M0

2024 Q1

2024 Q2

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2026 Q1

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 9, 2026

近期内幕交易记录

CERO 高管卖出股份 · CERO 董事内幕交易 · SEC Form 4申报

显示最近 18 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Mar 31, 2025	ATWOOD BRIAN G Director	Option	294,460	$0.00	$29	490,534	Form 4
Dec 11, 2024	YK Bioventures Opportunities GP I, LLC 10 percent owner	Sale	1,343,801	$0.08	$108K	17,618,618	Form 4
Dec 12, 2024	YK Bioventures Opportunities GP I, LLC 10 percent owner	Sale	1,614,541	$0.07	$113K	16,004,077	Form 4
Dec 13, 2024	YK Bioventures Opportunities GP I, LLC 10 percent owner	Sale	2,998,908	$0.06	$180K	13,005,169	Form 4
Dec 6, 2024	YK Bioventures Opportunities GP I, LLC 10 percent owner	Sale	1,236,874	$0.12	$148K	21,383,909	Form 4
Dec 9, 2024	YK Bioventures Opportunities GP I, LLC 10 percent owner	Sale	850,543	$0.11	$94K	20,533,366	Form 4
Dec 10, 2024	YK Bioventures Opportunities GP I, LLC 10 percent owner	Sale	1,570,947	$0.09	$141K	18,962,419	Form 4
Oct 10, 2024	YK Bioventures Opportunities GP I, LLC 10 percent owner	Sale	3,250,000	$0.10	$325K	22,620,783	Form 4
Sep 25, 2024	LAPORTE KATHLEEN Director	Option	965,997	$1000.00	$966.00M⚡	965,997	Form 4
Sep 25, 2024	Ehrlich Christopher B Interim Chairman and CEO · Director	Option	5,312,983	$1000.00	$5.31B⚡	5,791,808	Form 4
Sep 25, 2024	ATWOOD BRIAN G Director	Option	19,358,578	$1000.00	$19.36B⚡	19,607,313	Form 4
Feb 14, 2024	PHOENIX BIOTECH SPONSOR, LLC 10 percent owner	Other	1,125,000	—	—	4,171,246	Form 4
Feb 14, 2024	PHOENIX BIOTECH SPONSOR, LLC 10 percent owner	Other	4,171,246	—	—	1,000,000	Form 4
Feb 14, 2024	LAPORTE KATHLEEN Director	Other	5,828	—	—	5,828	Form 4
Feb 14, 2024	Ehrlich Christopher B Director	Other	1,125,000	—	—	4,171,246	Form 4
Feb 14, 2024	Ehrlich Christopher B Director	Other	4,171,246	—	—	1,000,000	Form 4
Feb 14, 2024	Ehrlich Christopher B Director	Other	478,825	—	—	478,825	Form 4
Feb 14, 2024	Ehrlich Christopher B Director	Other	3,600	—	—	3,600	Form 4

ATWOOD BRIAN G

Director

Option

日期

Mar 31

股数

294,460

均价

$0.00

总金额

$29

View Form 4 on SEC.gov

YK Bioventures Opportunities GP I, LLC

10 percent owner

Sale

日期

Dec 11

股数

1,343,801

均价

$0.08

总金额

$108K

View Form 4 on SEC.gov

YK Bioventures Opportunities GP I, LLC

10 percent owner

Sale

日期

Dec 12

股数

1,614,541

均价

$0.07

总金额

$113K

View Form 4 on SEC.gov

YK Bioventures Opportunities GP I, LLC

10 percent owner

Sale

日期

Dec 13

股数

2,998,908

均价

$0.06

总金额

$180K

View Form 4 on SEC.gov

YK Bioventures Opportunities GP I, LLC

10 percent owner

Sale

日期

Dec 6

股数

1,236,874

均价

$0.12

总金额

$148K

View Form 4 on SEC.gov

YK Bioventures Opportunities GP I, LLC

10 percent owner

Sale

日期

Dec 9

股数

850,543

均价

$0.11

总金额

$94K

View Form 4 on SEC.gov

YK Bioventures Opportunities GP I, LLC

10 percent owner

Sale

日期

Dec 10

股数

1,570,947

均价

$0.09

总金额

$141K

View Form 4 on SEC.gov

YK Bioventures Opportunities GP I, LLC

10 percent owner

Sale

日期

Oct 10

股数

3,250,000

均价

$0.10

总金额

$325K

View Form 4 on SEC.gov

LAPORTE KATHLEEN

Director

Option

日期

Sep 25

股数

965,997

均价

$1000.00

总金额

$966.00M ⚡

View Form 4 on SEC.gov

Ehrlich Christopher B

Interim Chairman and CEO · Director

Option

日期

Sep 25

股数

5,312,983

均价

$1000.00

总金额

$5.31B ⚡

View Form 4 on SEC.gov

ATWOOD BRIAN G

Director

Option

日期

Sep 25

股数

19,358,578

均价

$1000.00

总金额

$19.36B ⚡

View Form 4 on SEC.gov

PHOENIX BIOTECH SPONSOR, LLC

10 percent owner

Other

日期

Feb 14

股数

1,125,000

均价

—

总金额

—

View Form 4 on SEC.gov

PHOENIX BIOTECH SPONSOR, LLC

10 percent owner

Other

日期

Feb 14

股数

4,171,246

均价

—

总金额

—

View Form 4 on SEC.gov

LAPORTE KATHLEEN

Director

Other

日期

Feb 14

股数

5,828

均价

—

总金额

—

View Form 4 on SEC.gov

Ehrlich Christopher B

Director

Other

日期

Feb 14

股数

1,125,000

均价

—

总金额

—

View Form 4 on SEC.gov

Ehrlich Christopher B

Director

Other

日期

Feb 14

股数

4,171,246

均价

—

总金额

—

View Form 4 on SEC.gov

Ehrlich Christopher B

Director

Other

日期

Feb 14

股数

478,825

均价

—

总金额

—

View Form 4 on SEC.gov

Ehrlich Christopher B

Director

Other

日期

Feb 14

股数

3,600

均价

—

总金额

—

View Form 4 on SEC.gov

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 CERO 内幕交易

CERO 内幕交易

CERo Therapeutics Holdings, Inc.（CERO）内幕交易数据来源于公司内部人（包括CERO）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。CERO内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看CERo Therapeutics Holdings, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

CERO 内幕交易 · 5个问题

CERo Therapeutics Holdings, Inc.（CERO）的内部人包括高管和董事，如CERO等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

CERO 董事内幕交易CERO 内部人名单CERo Therapeutics Holdings, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026